By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Брафтови

CheckCompareThe price unknown
Can't order it
  1. Active ingredients
  2. Pharmacological Group
  3. ATX code
  4. Contraindications of the components
  5. Side effects of the components
  6. Manufacturers of the drug

Active ingredients

Pharmacological Group

Antitumor agents - protein kinase inhibitors

ATX code

 L01EC03 Энкорафениб.

Contraindications of the components

Противопоказания Enoxacin.

 Гиперчувствительность (в тч к фторхинолонам, нафтиридинам), дефицит глюкозо-6-фосфат-дегидрогеназы, эпилепсия.

Использование препарата Enoxacin при кормлении грудью.

 Категория действия на плод по FDA. с.

Side effects of the components

Побочные эффекты Enoxacin.

 Тошнота. рвота. боль в эпигастрии. диарея. повышение активности печеночных ферментов в крови. миалгия. артралгия. фотосенсибилизация. кожная сыпь. зуд. головная боль. расстройства внимания. судорожные припадки. одышка. кашель. кровохарканье. тахикардия. артериальная гипотензия. вагинальный монилиаз. эозинофилия.

Manufacturers (or distributors) of the drug

Almaс Pharma Services
Catalent Pharma Solutions Inc.
Pierre Fabre Medicament
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.